Evolent Health (EVH)
(Delayed Data from NYSE)
$19.74 USD
+0.49 (2.55%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $19.75 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
EVH 19.74 +0.49(2.55%)
Will EVH be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for EVH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EVH
Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say
Evolent Health (EVH) Q1 Earnings and Revenues Top Estimates
EVH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Does Evolent Health (EVH) Have the Potential to Rally 34.46% as Wall Street Analysts Expect?
Wall Street Analysts Predict a 35.7% Upside in Evolent Health (EVH): Here's What You Should Know
New Strong Buy Stocks for January 5th
Other News for EVH
First Week of August 16th Options Trading For Evolent Health (EVH)
Evolent Health Buy Rating Affirmed by Constantine Davides on Recovery Prospects and Growth Potential
Fly Intel: After-Hours Movers
RA Capital reports 7.1% passive stake in Evolent Health
Analysts Are Bullish on These Healthcare Stocks: Xenon (XENE), Evolent Health (EVH)